We would emphasize that Canada actually acted quite quickly in enacting domestic legislation that gave the Canadian government the ability to issue compulsory licences. This happened early on in the pandemic. This was prior to there being any vaccines or therapeutics that were approved for use. Canada, as I said, gave itself the ability to issue compulsory licences to effectively waive intellectual property rights in the event that Canada needed to scale up the manufacturing of a COVID-19 tool.
This is effectively the speed and the precision that's needed to respond to a global pandemic today. We of course recognize that intellectual property rights and rules are not the only barrier, but I think all of us would agree that they represent part of the problem, and waiving these rules represents part of the solution in addition to the many other things that need to be put into place. I think—